The Intersection of Science, Technology, and Human-Oriented R&D CLINICAL RESEARCH GUIDE Scientific and Operational Roadmap of Drug Development Processes
Introduction: From a Molecule to Life-Saving Treatment Clinical research, one of the most critical processes of modern medicine, is a meticulous and multi-staged journey that a new drug molecule takes from the laboratory to the patient. As Medicalpoint Global Health Institute, our vision is to manage this process not just as a testing phase, but as an innovation cycle that extends human life and enhances quality of life. The futuristic design language within the corridors of our institute represents the boundary-pushing nature of our healthcare services and scientific research.
Part 1: Pre-Clinical Process and Foundations
Before transitioning to human studies, the primary biological effects and toxicity profile of the drug are examined through research conducted in laboratory environments (in vitro) and living models (in vivo). Molecules that succeed in this phase gain “Investigational New Drug” status and begin their journey through clinical phases.
1.1. Good Clinical Practice (GCP) Standards
All our clinical research is conducted in full compliance with international Good Clinical Practice (GCP) protocols, which maintain participant rights and data reliability at the highest level. These standards mandate that every step of the research be audited by ethics committees.
Part 2: Detailed Analysis of Clinical Phases
The drug development process consists of four fundamental phases, each serving a distinct scientific purpose:
PHASE 1: Safety and Dosage Determination
This is the first human step of clinical research.
Scope: Generally 20 to 100 healthy volunteers or specific patient groups.
Focus: Determining the safety of the drug, its side effects, how it is processed in the body (metabolism), and the maximum tolerable dose.
Thanks to our institute’s advanced monitoring technologies and expert teams, real-time data analysis is performed during Phase 1 studies to keep participant safety at the maximum level.
PHASE 2: Efficacy and Safety Confirmation
This is the phase where the therapeutic effect of the drug on the targeted disease is tested for the first time.
Scope: A volunteer group of 100 to 300 individuals with the relevant disease.
Focus: Proving the efficacy of the drug, establishing the dose-response relationship, and confirming its safety in a wider group.
PHASE 3: Large-Scale Comparative Analysis
This is the most comprehensive test of the drug before it is launched to the market.
Scope: Multi-center and international studies generally consisting of thousands of volunteer participants.
Focus: Statistically proving the efficacy and side effects of the new treatment by comparing it with current standard treatments or a placebo.
Statistical Accuracy: The data obtained in this phase forms the basis for the approval of the drug by health authorities (FDA, EMA, TITCK).
PHASE 4: Post-Marketing Monitoring and Real-World Data
This is the ongoing process after the drug receives approval and is made available for general use.
Scope: A very large and heterogeneous population to whom the drug is prescribed.
Focus: Detecting rare side effects, monitoring long-term safety, and analyzing the performance of the drug under real-world conditions.
Part 3: Strategic Advantages of Medicalpoint
The core elements that make our institute a global research base are the combination of our physical infrastructure and our academic depth.
Advanced Diagnostic and Monitoring Technologies: Our systems, such as 3 Tesla MRI, Da Vinci Robotic Surgery, and PET-CT, enable us to obtain the highest resolution data in clinical research.
Multidisciplinary Expert Staff.
Digital Transformation and Data Security: Thanks to our “Paperless Hospital” model, data is processed flawlessly in a digital environment and protected by cybersecurity protocols.
Part 4: Volunteer Participation and Ethical Responsibility
Volunteer participants lie at the heart of clinical research. While offering volunteers early access to modern treatment options, our institute guarantees that all processes are transparent and based on voluntary participation.
Informed Consent Form: Every participant is informed in detail about all the risks and potential benefits of the research.
Right of Withdrawal: Volunteers have the right to leave the study at any stage of the research without providing any justification.
Conclusion: Pioneering the Medicine of Tomorrow Medicalpoint Global Health Institute is building a scientific bridge extending from Izmir to the world. Our methodological excellence in drug development processes combines with our passion to deliver the newest and most effective treatments to our patients. The future of health rises upon these rigorous clinical studies we conduct today.